221 related articles for article (PubMed ID: 24105052)
21. Neurotoxicity of local administration of two nitrosoureas in malignant gliomas.
Yamashima T; Yamashita J; Shoin K
Neurosurgery; 1990 May; 26(5):794-9. PubMed ID: 2352597
[TBL] [Abstract][Full Text] [Related]
22. Quantitation of O6-methylguanine-DNA methyltransferase gene messenger RNA in gliomas by means of real-time RT-PCR and clinical response to nitrosoureas.
Tanaka S; Oka H; Fujii K; Watanabe K; Nagao K; Kakimoto A
Cell Mol Neurobiol; 2005 Sep; 25(6):1067-71. PubMed ID: 16392037
[TBL] [Abstract][Full Text] [Related]
23. Novel approaches to glioma drug design and drug screening.
Patil SA; Hosni-Ahmed A; Jones TS; Patil R; Pfeffer LM; Miller DD
Expert Opin Drug Discov; 2013 Sep; 8(9):1135-51. PubMed ID: 23738794
[TBL] [Abstract][Full Text] [Related]
24. Expert opinion on translational research for advanced glioblastoma treatment.
Cui X; Wang Y; Zhou J; Wang Q; Kang C
Cancer Biol Med; 2023 Apr; 20(5):344-52. PubMed ID: 37092846
[TBL] [Abstract][Full Text] [Related]
25. Can in-vitro chemoresponse assays help find new treatment regimens for malignant gliomas?
Linz U; Ulus B; Neuloh G; Clusmann H; Oertel M; Nolte K; Weis J; Heussen N; Gilsbach JM
Anticancer Drugs; 2014 Apr; 25(4):375-84. PubMed ID: 24423983
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy for gliomas.
Chang SM; Prados MD
Curr Opin Oncol; 1995 May; 7(3):207-13. PubMed ID: 7654821
[TBL] [Abstract][Full Text] [Related]
27. Emerging drugs for malignant glioma.
Mason WP
Expert Opin Emerg Drugs; 2008 Mar; 13(1):81-94. PubMed ID: 18321150
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy for malignant gliomas.
Kornblith PL; Walker M
J Neurosurg; 1988 Jan; 68(1):1-17. PubMed ID: 3275753
[TBL] [Abstract][Full Text] [Related]
29. [Nucleoside analogs in the treatment of primary malignant brain tumors].
Kryczka T; Grieb P
Neurol Neurochir Pol; 2003; 37(3):687-701. PubMed ID: 14593762
[TBL] [Abstract][Full Text] [Related]
30. Overcoming therapeutic resistance in malignant gliomas: current practices and future directions.
Chakravarti A; Palanichamy K
Cancer Treat Res; 2008; 139():173-89. PubMed ID: 18236717
[TBL] [Abstract][Full Text] [Related]
31. Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas.
Levin VA; Ictech SE; Hess KR
CNS Oncol; 2018 Apr; 7(2):CNS16. PubMed ID: 29378419
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol.
da Fonseca CO; Landeiro JA; Clark SS; Quirico-Santos T; da Costa Carvalho Mda G; Gattass CR
Surg Neurol; 2006; 65 Suppl 1():S1:2-1:8; discussion S1:8-1:9. PubMed ID: 16427438
[TBL] [Abstract][Full Text] [Related]
33. Endovascular therapies for malignant gliomas: Challenges and the future.
Su YS; Ali R; Feroze AH; Li G; Lawton MT; Choudhri O
J Clin Neurosci; 2016 Apr; 26():26-32. PubMed ID: 26857294
[TBL] [Abstract][Full Text] [Related]
34. Novel multi-drugs incorporating hybrid-structured nanofibers enhance alkylating agent activity in malignant gliomas.
Liu SJ; Yang ST; Chen SM; Huang YC; Lee WH; Ho J; Chen YC; Tseng YY
Ther Adv Med Oncol; 2019; 11():1758835919875555. PubMed ID: 31632467
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives.
Liu J; Yang F; Hu J; Zhang X
CNS Neurosci Ther; 2024 May; 30(5):e14715. PubMed ID: 38708806
[TBL] [Abstract][Full Text] [Related]
36. Treating malignant glioma in Chinese patients: update on temozolomide.
Chang L; Su J; Jia X; Ren H
Onco Targets Ther; 2014; 7():235-44. PubMed ID: 24600235
[TBL] [Abstract][Full Text] [Related]
37. High dose chemotherapy for the treatment of malignant brain tumors.
Petersdorf SH; Livingston RB
J Neurooncol; 1994; 20(2):155-63. PubMed ID: 7807192
[TBL] [Abstract][Full Text] [Related]
38. Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top".
Simonelli M; Persico P; Perrino M; Zucali PA; Navarria P; Pessina F; Scorsetti M; Bello L; Santoro A
Cancer Treat Rev; 2018 Sep; 69():121-131. PubMed ID: 29966936
[TBL] [Abstract][Full Text] [Related]
39. Genotoxic therapy and resistance mechanism in gliomas.
Lang F; Liu Y; Chou FJ; Yang C
Pharmacol Ther; 2021 Dec; 228():107922. PubMed ID: 34171339
[TBL] [Abstract][Full Text] [Related]
40. Tumor Treating Fields in the Management of Patients with Malignant Gliomas.
Ghiaseddin AP; Shin D; Melnick K; Tran DD
Curr Treat Options Oncol; 2020 Jul; 21(9):76. PubMed ID: 32734509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
